Skip to content

13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP

SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 32 holding rows worth $158,379,902.

Accession
0001931118-26-000009
Filed
2026-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A holdings report, 32 entries on the cover page, a total value of $158,379,902 stated on the cover page (in dollars after the unit check, H1), rows summing to $158,379,902 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
COGENT BIOSCIENCES INC19240Q201COM343,284$13,285,091dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock53,916$13,197,019dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share430,600$11,828,582dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW287,583$10,700,963dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock524,224$9,776,778dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock51,053$9,561,206dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS188,282$8,856,785dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM853,685$8,699,050dollars as filed
IMMUNOVANT INC45258J102COM208,368$8,028,419dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK191,313$7,040,318dollars as filed
CLIMB BIO INC28658R106COMMON STOCK521,082$6,794,909dollars as filed
Adlai Nortye00704R109SPONSORED ADS552,501$6,353,762dollars as filed
SAVARA INC805111101COM977,460$6,021,154dollars as filed
MAPLIGHT THERAPEUTICS INC56565P103COMMON STOCK125,432$4,495,483dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM406,077$4,397,814dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock7,172$3,886,005dollars as filed
VAXCYTE INC COM92243G108Stock66,793$3,882,677dollars as filed
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR12,273$3,497,437dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK1,278,652$3,478,020dollars as filed
ZAI LAB LTD ADR98887Q104ADR155,813$2,960,447dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK63,156$2,778,232dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK30,456$2,138,011dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock257,675$1,363,101dollars as filed
CYBIN INC23256X407COM NEW204,424$1,351,243dollars as filed
KINIKSA PHARMACEUTICALS INTL P ORD SHS CL AG52694109Stock18,867$1,206,545dollars as filed
ROIVANT SCIENCES LTDG76279101SHS25,623$906,798dollars as filed
TONIX PHARMACEUTICALS HOLDIN890260839COMMON STOCK63,648$812,148dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK121,457$463,966dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW14,175$354,375dollars as filed
BOUNDLESS BIO INC10170A100COM55,356$138,390dollars as filed
BIOMEA FUSION INC09077A106CMN250,000$85,306dollars as filed
VYNE THERAPEUTICS INC92941V308COM61,269$39,868dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001931118-26-000009this filing2026-08-14acceptance time not in the bulk data set